TREML2 protein expression levels rise along with AD progression in vivo [366] and after LPS stimulation in primary microglia in vitro, both proving TREML2 involvement in microglia-induced neuroinflammation [367]. The gene discussed is TREML2; the disease is Alzheimer disease.